B O O K - American College of Rheumatology

wednesday
A410
Takayasu’s Arteritis
Moderators: Peter A. Merkel, MD, MPH; Boston University
School of Medicine; West Newton, MA
Rafi Haner Direskeneli, MD; Marmara Medical University School
of Medicine; Istanbul, Turkey
1:00 PM
Takayasu’s Arteritis and Giant-Cell Arteritis - Two Diseases or
Part of the Same Spectrum?
Cornelia M. Weyand, MD, PhD; Stanford University School of
Medicine; Stanford, CA
1:10 PM
Disease Assessment in Takayasu’s Arteritis
Rafi Haner Direskeneli, MD; Marmara Medical University School
of Medicine; Istanbul, Turkey
1:20 PM
Treatment of Takayasu’s Arteritis
Peter A. Merkel, MD, MPH; Boston University School of
Medicine; West Newton, MA
1:30 PM
Clinical Trials in Takayasu’s Arteritis
Carol A. Langford, MD, MHS; Cleveland Clinic Foundation;
Cleveland, OH
1:40 PM
Panel Discussion
Session Overview:
Diagnosis, disease assessment, and management of Takayasu’s
Arteritis is currently dependant on limited evidence and
there are no sufficiently-validated disease assessment tools
or controlled drug trials. Recent data suggests that giant-cell
arteritis and Takayasu’s Arteritis might both be in a spectrum
of vasculitis with overlapping clinical and pathophysiologic
features. There is increased world-wide interest in research
into Takayasu’s Arteritis as evidenced by recent publications
of large patient series, adoption of new imaging modalities,
development of new disease assessment tools, and initiation
of international multicenter clinical trials. Past ACR Vasculitis
Study Groups have attracted large audiences of both clinical
investigators and clinicians.
Upon completion of this session, participants should be able to:
• recognize the similarities and differences of giant cell
arteritis and Takayasu’s arteritis both clinically and
pathophysiologically; discuss the impact of these data on
treatment and research
• review current criteria for activity/remission and damage in
Takayasu’s arteritis and the challenges to disease assessment
• review the clinical data on treatment of Takayasu’s arteritis
and discuss the unmet medical needs in the treatment of
Takayasu’s arteritis
• outline current clinical trials in Takayasu’s arteritis and the
challenges for conducting such trials
A404
Teaching and Assessing Arthrocentesis
Moderators: Joanne Valeriano-Marcet, MD; University of South
Florida; Tampa, FL
Helen E. Bateman, MD; James A. Haley Veterans Affairs Hospital,
University of Southern Florida; Tampa, FL
Ashley G. Sterrett, MD; James A. Haley Veterans Affairs Hospital;
Tampa, FL
1:00 PM
Achievement and Maintenance of Procedural Competency
Through a Cadaver-based Mini-procedural Evaluation Exercise
(mini-PEX)
Kenneth S. O’Rourke, MD; Wake Forest University School of
Medicine; Winston-Salem, NC
1:20 PM
Do or Do Not, There is No Try: Teaching Arthrocentesis and
Injection Skills Using Competency
Gregory C. Gardner, MD; University of Washington; Seattle, WA
1:40 PM
Validating Simulators - or How Hard Can it Be?
Maren L. Mahowald, MD; University of Minnesota Medical
School; Minneapolis, MN
Session Overview:
Joint injection training is a necessary part of the skills required
for internal medicine residents and advanced subspecialty
rheumatology fellows. Additionally the decreasing numbers of
rheumatology specialists will require primary care providers to
perform these procedures. Prior studies in the literature support
the use of joint injection training to increase comfort levels for
internal medicine residents, primary care providers, and medical
students in performing these procedures.The importance of
this study group is to increase interest and awareness in using
simulation as a safe way to practice and assess competency in
the necessary skills prior to injection on real patients. Further
research is necessary to define the exact role and limitation of
simulation to teach and assess competency of arthrocentesis
skillsand are hoping to raise enthusiasm for further research
efforts in this area.
Upon completion of this session, participants should be able to:
• identify the importance of validating a simulator
• discuss whether all of the key elements in a joint injection
procedure can be measured with a simulator
• learn how to assess competency in joint injection training
• describe the incorporation of rubric scoring of competency
into a formative assessment of procedural skills of
rheumatology fellows
ACR Special Session
1:00 - 2:30 PM
A406
Career Opportunities in Rheumatology: Making a
Choice BR Ed. f
Moderator: David D. Sherry, MD; The Children’s Hospital of
Philadelphia; Philadelphia, PA
1:00 PM
Basic Research Rheumatology
James N. Jarvis, MD; Oklahoma University Health Sciences;
Oklahoma City, OK
112
2010 Program Book